Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
12.63
-0.39 (-3.00%)
Feb 27, 2026, 4:00 PM EST - Market closed
Beta Bionics Market Cap
Beta Bionics has a market cap or net worth of $560.55 million as of February 27, 2026. Its market cap has decreased by -41.18% in one year.
Market Cap
560.55M
Enterprise Value
348.72M
1-Year Change
-41.18%
Ranking
Category
Stock Price
$12.63
Market Cap Chart
Since the IPO on January 30, 2025, Beta Bionics's market cap has decreased from $695.12M to $560.55M, a decrease of -19.36%. That is a compound annual growth rate of -18.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 560.55M | -58.21% |
| Dec 31, 2025 | 1.34B | 92.98% |
| Jan 30, 2025 | 695.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avanos Medical | 673.84M |
| Tactile Systems Technology | 671.15M |
| Bioventus | 593.41M |
| Perspective Therapeutics | 576.41M |
| Varex Imaging | 566.75M |
| Cytek Biosciences | 562.61M |
| Pacific Biosciences of California | 537.40M |
| Orthofix Medical | 528.70M |